Osaic Holdings’s Capricor Therapeutics CAPR Stock Holding History
Bought
Maintained
Sold
Other funds holding CAPR
SCM
TCM
VCM
RCM
JHC
Osaic Holdings's CAPR Position: Q1 2026 in Review
Osaic Holdings reduced its Capricor Therapeutics (CAPR) stake by 9.9% in Q1 2026, selling an estimated $105K and leaving 35,950 shares worth $1.09M. The position accounts for ﹤0.01% of the portfolio, ranked #2625.
Osaic Holdings first reported a position in CAPR in Q3 2021 and has held it in 19 quarters since. The position peaked at $3.66M in Q3 2024. 177 funds tracked by Wall St. Rank hold CAPR as of Q1 2026.
- Osaic Holdings held 35,950 shares of Capricor Therapeutics worth $1.09M as of Q1 2026.
- Osaic Holdings sold 3,931 Capricor Therapeutics shares in Q1 2026, an estimated $105K.
- Capricor Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #2625 holding.
- Osaic Holdings first reported a position in Capricor Therapeutics in Q3 2021 and has held it in 19 quarters since.
- Osaic Holdings's Capricor Therapeutics position peaked at $3.66M in Q3 2024.
- 177 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q1 2026.
Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.